Off-label use of medicines in children: can available evidence avoid useless paediatric trials?: The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease

Author： Tafuri Giovanni   Trotta Francesco   Leufkens Hubert   Martini Nello   Sagliocca Luciano   Traversa Giuseppe  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.65, Iss.2, 2009-02, pp. : 209-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gastroesophageal Reflux in Children: Pathogenesis, Prevalence, Diagnosis, and Role of Proton Pump Inhibitors in Treatment

By Gold B.D.  

Pediatric Drugs, Vol. 4, Iss. 10, 2002-01 ,pp. : 673-685

Adis International

Access to resources Recommend Favorite

Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors

By Johnson David A   Levy III Benjamin H  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1541-1548

Informa Healthcare

Access to resources Recommend Favorite

Novel effects other than antisecretory action and off-label use of proton pump inhibitors

By Suzuki Hidekazu   Hibi Toshifumi  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 59-67

Informa Healthcare

Access to resources Recommend Favorite

Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease

By Tolman K.G.   Chandramouli J.   Fang J.C.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1171-1194

Informa Healthcare

Access to resources Recommend Favorite

Off-label and unlicensed use of antidotes in paediatric patients

By Lifshitz Matityahu   Gavrilov Vladimir   Gorodischer Rafael  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 11, 2001-01 ,pp. : 839-841

Springer Publishing Company

Access to resources Recommend Favorite